I've joined you in ALTU today. Been following it for some time actually.
I've been listening to their calls over and over the past few weeks and what sold me on it are (not in order): 1-Growth Hormone (ALTU-238) - On the Morgan Stanley call I believe it sure sounded like Genentech was about to get an x-US partner which would trigger milestones. 2-ALTU-237 - From the calls it seems it will move through development quickly because of high unmet need (Primary hyperoxaluria). They indicated a 250 million market, I've owned BMRN, TKT and UTHR. Lets see rare, life threatening indication with no treatment - If the drug works well it will be more than that! Then they have 2 other potential indications. 3-Protein Crystalizition technology - 70 proteins crystallized and haven't come across one yet that they couldn't. If their business development gets active I think this could offer a lot of growth potential!
OK I have a question for you or anyone that may have an ideas. The Genentech royalty all I heard is "double digits". Any hints at where is it closer to 10 or in the 20's? TIA
PS you seem to be invested/like several stocks that I follow. Any others you like?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.